Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SABS | US
-0.35
-11.25%
Healthcare
Biotechnology
30/06/2024
17/10/2024
2.76
3.01
3.06
2.62
SAB Biotherapeutics Inc. a clinical-stage biopharmaceutical company engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at infectious diseases and immune and autoimmune disorders including infectious diseases influenza CDI type 1 diabetes organ transplantation and oncology as well as immunology gastroenterology and respiratory diseases. The company also uses its DiversitAb immunotherapy platform to produce fully-human polyclonal antibodies without the need for human donors or plasma. In addition its lead product candidates include SAB-185 a fully-human polyclonal antibody therapeutic candidate that is in Phase III clinical trial for the treatment of COVID-19; and SAB-176 a fully-human polyclonal antibody therapeutic candidate that is in development for the treatment or prevention of severe influenza. Further the company's pre-clinical product candidates in development for autoimmune diseases include SAB-142 for type 1 diabetes and organ transplant induction/rejection. SAB Biotherapeutics Inc. was founded in 2014 and is headquartered in Sioux Falls South Dakota.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Weakness based on declining price with high volume
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
170.4%1 month
153.3%3 months
111.2%6 months
99.5%-
-
0.48
0.12
0.09
-1.49
1.21
-
-40.91M
25.47M
25.47M
-
-3.88K
-60.00
207.70
-122.49
1.12
0.59
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.85
Range1M
1.03
Range3M
1.21
Rel. volume
1.43
Price X volume
457.83K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Kala Pharmaceuticals Inc | KALA | Biotechnology | 5.1119 | 28.02M | -2.82% | n/a | 268.29% |
Mawson Infrastructure Group Inc. Common Stock | MIGI | Biotechnology | 1.45 | 26.90M | -0.68% | n/a | 571.64% |
Akari Therapeutics Plc | AKTX | Biotechnology | 2.21 | 26.84M | -12.30% | n/a | -27.01% |
Common Stock | NRBO | Biotechnology | 3.16 | 26.82M | 6.76% | n/a | 0.90% |
PLUR | PLUR | Biotechnology | 4.8089 | 26.31M | -2.85% | n/a | 30845.83% |
Tonix Pharmaceuticals Holding Corp | TNXP | Biotechnology | 0.1794 | 25.11M | 12.83% | n/a | 21.99% |
Iterum Therapeutics plc | ITRM | Biotechnology | 1.09 | 24.75M | 5.83% | n/a | -198.11% |
iBio Inc | IBIO | Biotechnology | 2.85 | 24.62M | 0.00% | n/a | 20.92% |
CytoMed Therapeutics Limited Ordinary Shares | GDTC | Biotechnology | 2.1301 | 24.58M | 2.41% | n/a | 3.98% |
Caladrius Biosciences Inc | LSTA | Biotechnology | 2.94 | 24.46M | 0.00% | n/a | 0.58% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.6 | 19.19M | 0.80% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 0.98 | 17.70M | -3.92% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5763 | 8.36M | -11.91% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -1.49 | 0.53 | Cheaper |
Ent. to Revenue | 1.21 | 4,005.99 | Cheaper |
PE Ratio | - | 40.42 | - |
Price to Book | 0.48 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 111.20 | 72.92 | Riskier |
Debt to Equity | 0.12 | -1.24 | Expensive |
Debt to Assets | 0.09 | 0.25 | Cheaper |
Market Cap | 25.47M | 3.78B | Emerging |